Medicare AdvantageCoverageMedium impact
MA11.013c, Percutaneous Left Atrial Appendage (LAA) Closure for Non-Valvular Atrial Fibrillation (NVAF)
Independence Blue Cross·Cardiology, Cardiothoracic Surgery·Medical Policy
Effective date
Apr 1, 2026
We identified it
Jun 19, 2026
Summary
Policy MA11.013c has been reissued effective April 1, 2026, establishing or updating coverage guidelines for percutaneous left atrial appendage (LAA) closure procedures in Medicare Advantage beneficiaries with non-valvular atrial fibrillation. The billing team must review the full policy document to identify specific changes to coverage criteria, prior authorization requirements, billing codes, and medical necessity documentation from the previous version.
Action Required
By March 15, 2026: Billing team and providers must obtain and review the complete MA11.013c policy document at the provided URL. Identify differences from the previous policy version. Update prior authorization workflows in billing software if requirements have changed. Notify cardiology and interventional cardiology providers of any new medical necessity documentation requirements or coverage criteria changes. Verify that all LAA closure claims (CPT 93590 and related codes) comply with the new policy effective April 1, 2026. Failure to comply with updated coverage criteria will result in claim denials and potential recoupment of payments.